Statherin vs LRAP

Head-to-head comparison of Statherin (Human statherin) and LRAP (Leucine-Rich Amelogenin Peptide (LRAP)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyStatherinLRAP
CategoryDental & OralDental & Oral
Full NameHuman statherinLeucine-Rich Amelogenin Peptide (LRAP)
Molecular Weight5380 Daapprox. 6.6 kDa
Half-Lifeminutes to hours in salivaunknown
Amino Acids4359
Typical Dose1-50 µM in experimental systems
RouteTopical/Intraorallocal biomaterial
Purity≥98%≥98%
Studies Count9585
Research StatusPre-clinicalPre-clinical

Statherin Benefits

  • enamel pellicle stabilization
  • calcium phosphate homeostasis
  • remineralization support
  • anti-adhesion

LRAP Benefits

  • enamel/dentin regeneration
  • odontogenic signaling
  • mineralization support

Statherin Dosing

topical peptide exposure in vitro or ex vivo|salivary-mimetic coating studies|surface-conditioning protocols

LRAP Dosing

No dosing data available

Statherin Side Effects

  • minimal systemic effects expected
  • surface adsorption variability
  • rapid enzymatic breakdown

LRAP Side Effects

  • experimental only
  • unknown immunogenicity
  • biomaterial-dependent effects

Research Overview

Statherin

Statherin has been extensively studied as a key regulator of enamel mineral equilibrium and pellicle biology. It is used in biomimetic dentistry research to model or improve enamel protection and remineralization.

LRAP

LRAP is one of the better-known amelogenin-derived peptides in regenerative dentistry because it can influence mineralization-related cell behavior. It remains a research peptide, but it is highly relevant to enamel repair and tooth-tissue engineering.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Statherin stacks with:

fluorideCPP-ACPhydroxyapatite

LRAP stacks with:

LRAPAmelogenin-derived peptide
salivary-peptideenamelpellicleremineralizationdentalenamel-repairregenerativeamelogenin